Lightricks Partners With Shutterstock for Video Training Data to Advance Open Source LTXV Video AI Generative Video Model
Shutterstocks' partnership with Lightricks is the first of a new data licensing…
Ribbon Supercharges Diabolocom’s AI-Powered Cloud Contact Center Software With High Density, Low Power Data Center Interconnect
Facilitates high-speed, scalable, and cost-effective data transfer PLANO, Texas, Dec. 11, 2024…
Ribbon Supercharges Diabolocom’s AI-Powered Cloud Contact Center Software With High Density, Low Power Data Center Interconnect
Facilitates high-speed, scalable, and cost-effective data transfer PLANO, Texas, Dec. 11, 2024…
Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium
December 11, 2024 07:05 ET | Source: Celcuity Inc. Median overall survival…
Artificial Intelligence Substantial Influence on Data Center Industry Redefining Operations
PALM BEACH, Fla., Dec. 10, 2024 (GLOBE NEWSWIRE) -- FN Media Group…
Disc Medicine Presents Positive Clinical and Translational Data Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting
December 09, 2024 12:00 ET | Source: Disc Medicine Inc Positive updates…
Editas Medicine Reports Updated Clinical Data from the RUBY Trial of Reni-cel in Patients with Severe Sickle Cell Disease at the American Society of Hematology (ASH) Annual Meeting
Poster presentation at ASH on Monday, December 9 at 6:00 p.m. PT…
CRISPR Therapeutics Presents Data atthe 2024 American Society of Hematology (ASH) Annual Meeting
December 09, 2024 12:00 ET | Source: CRISPR Therapeutics AG -Preliminary data…
Longer-term data for Novartis Scemblix reinforce superior efficacy with favorable safety and tolerability profile in adults with newly diagnosed CML
Scemblix demonstrated sustained superior major molecular response (MMR) vs. all investigator-selected TKIs…
C4 Therapeutics Presents Cemsidomide Phase 1 Data at the American Society for Hematology (ASH) Annual Meeting that Demonstrated Potential to Become Best-in-Class IKZF1/3 Degrader
December 08, 2024 12:30 ET | Source: C4 Therapeutics, Inc. In Multiple…